Allspring Global Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Allspring Global Investments’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-95,794	Closed	-$1.78M	–	2848
2023 Q3	$1.78M	Buy	95,794 +6,191	+7%	+$70K	﹤0.01%	1218
2023 Q2	$991K	Sell	89,603 -101,292	-53%	-$1.41M	﹤0.01%	1417
2023 Q1	$2.56M	Buy	190,895 +14,235	+8%	+$246K	﹤0.01%	1176
2022 Q4	$2.19M	Buy	176,660 +59,322	+51%	+$840K	﹤0.01%	1215
2022 Q3	$1.64M	Buy	117,338 +10,470	+10%	+$169K	﹤0.01%	1294
2022 Q2	$1.48M	Buy	106,868 +7,019	+7%	+$112K	﹤0.01%	1325
2022 Q1	$1.62M	Buy	99,849 +11,552	+13%	+$181K	﹤0.01%	1617
2021 Q4	$1.44M	Buy	+88,297	New	+$1.49M	﹤0.01%	1720

Allspring Global Investments's ICPT Position: Q4 2023 in Review

Allspring Global Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 95,794 shares — an estimated $1.78M sold.

Allspring Global Investments first reported a position in ICPT in Q4 2021 and held it in 8 quarters. The position peaked at $2.56M in Q1 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Allspring Global Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Allspring Global Investments sold 95,794 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.78M.
Allspring Global Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2021 and held it in 8 quarters.
Allspring Global Investments's Intercept Pharmaceuticals, Inc. position peaked at $2.56M in Q1 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.